Companies

ARDELYX, INC.

ARDX · CIK 0001437402 · operating

$6.47-1.22%Last updated Mar 3, 12:02 AM

Key Statistics

Valuation

Market Cap$1.59B
P/E
Fwd P/E11.86
PEG
P/S3.90
P/B9.47
EV/EBITDA-41.03
EV/Rev3.82

Profitability

Gross Margin
Op. Margin-10.06%
Net Margin-15.12%
ROE-36.90%
ROA-12.28%
FCF Margin-10.80%

Financial Health

Current Ratio4.31
Debt/Equity2.00
Free Cash Flow-$43.98M
Div. Yield

Growth & Other

Revenue Growth22.09%
EPS Growth-52.94%
Beta0.58
52W High$8.4
52W Low$3.21

About ARDELYX, INC.

ARDELYX, INC. (ARDX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.6 billion, ARDELYX, INC. is a small-cap company. The stock currently trades at $6.47, down 1.22% today, with a 52-week range of $3.21–$8.40. The company trades at a forward P/E of 11.9x.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$-0.26$-0.26-52.9%
2024$-0.17$-0.17+43.3%
2023$-0.30$-0.30+28.6%
2022$-0.42$-0.42+72.4%
2021$-1.52$-1.52
2020
2019
2018$0.21$0.21+0.0%
2017$0.21$0.21+132.3%
2016$-0.65$-0.65+0.0%
2015$-0.65$-0.65-209.5%
2014$-0.21$-0.21

Annual Reports (10-K) · 11 filings

Report DateFiledAccession Number
2025-12-312026-02-190001437402-26-000013SEC ↗
2024-12-312025-02-200001628280-25-006653SEC ↗
2023-12-312024-02-220001628280-24-006393SEC ↗
2022-12-312023-03-020001628280-23-006041SEC ↗
2021-12-312022-02-280001628280-22-004226SEC ↗
2020-12-312021-03-080001558370-21-002500SEC ↗
2019-12-312020-03-060001558370-20-002138SEC ↗
2018-12-312019-03-060001558370-19-001583SEC ↗
2017-12-312018-03-140001558370-18-002056SEC ↗
2016-12-312017-02-170001193125-17-047972SEC ↗
2015-12-312016-03-040001193125-16-493375SEC ↗